{"id":828361,"date":"2022-10-19T19:07:48","date_gmt":"2022-10-19T17:07:48","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/"},"modified":"2022-10-19T19:07:48","modified_gmt":"2022-10-19T17:07:48","slug":"edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/","title":{"rendered":"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company&#8217;s Remaining Shares"},"content":{"rendered":"\u00a0\n\n\nDIJON, France--(BUSINESS WIRE)--Regulatory News:\n\n\nOncodesign Services (Paris:ALONC) (FR0011766229 - ALONC), a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, representing 61.58% of its share capital (the \u201cControl Block \u201c), from its main shareholders, including Mr. Philippe Genne, Founder of Oncodesign Services, as well as certain key shareholders and several managers and minority shareholders, following the entry into exclusive negotiations on June 30, 2022.\n\n\nThe share price has been increased to \u20ac14.42 per share (initially <div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>\u00a0 DIJON, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News: Oncodesign Services (Paris:ALONC) (FR0011766229 &#8211; ALONC), a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, representing 61.58% of its share capital (the \u201cControl [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49624],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-828361","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-europe"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company&#039;s Remaining Shares - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company&#039;s Remaining Shares - BeBeez\" \/>\n<meta property=\"og:description\" content=\"\u00a0 DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Services (Paris:ALONC) (FR0011766229 - ALONC), a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, representing 61.58% of its share capital (the \u201cControl [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-19T17:07:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company&#8217;s Remaining Shares\",\"datePublished\":\"2022-10-19T17:07:48+00:00\",\"dateModified\":\"2022-10-19T17:07:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/\"},\"wordCount\":1809,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in Europe\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/\",\"name\":\"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company's Remaining Shares - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-10-19T17:07:48+00:00\",\"dateModified\":\"2022-10-19T17:07:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company&#8217;s Remaining Shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company's Remaining Shares - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/","og_locale":"en_US","og_type":"article","og_title":"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company's Remaining Shares - BeBeez","og_description":"\u00a0 DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Services (Paris:ALONC) (FR0011766229 - ALONC), a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, representing 61.58% of its share capital (the \u201cControl [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/","og_site_name":"BeBeez","article_published_time":"2022-10-19T17:07:48+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/"},"author":{"name":"","@id":""},"headline":"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company&#8217;s Remaining Shares","datePublished":"2022-10-19T17:07:48+00:00","dateModified":"2022-10-19T17:07:48+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/"},"wordCount":1809,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in Europe"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/","name":"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company's Remaining Shares - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-10-19T17:07:48+00:00","dateModified":"2022-10-19T17:07:48+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/edmond-de-rothschild-equity-strategies-iv-advised-by-elyan-partners-acquires-a-majority-stake-in-oncodesign-services-and-will-file-a-simplified-tender-offer-on-the-companys-remaining-shares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company&#8217;s Remaining Shares"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/828361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=828361"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/828361\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=828361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=828361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=828361"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=828361"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=828361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}